Skip 
Navigation Link

1215 South Walnut Ave.
Demopolis, AL 36732 map map 

Access to Care: 800.239.2901

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
FDA May Limit 'Risk Info' in Direct-to-Consumer TV Drug AdsFDA Announces Recall of Some Liquid Pharmaceutical ProductsIs FDA Taking Close Enough Look at Fast-Tracked Drugs?Steep Price Hikes Led to Drop in Use of 2 Heart Drugs at U.S. HospitalsAPA: Medical Discrimination Based on Size Stresses Patients2 of 3 U.S. Patients Keep Unused Painkillers After SurgeryMedical Reality Catches Up to Science FictionFDA Looks to Reduce Nicotine in CigarettesAHA Hands-Only CPR Training Kiosks Available at More Airports$100 Sweetens the Pot for a ColonoscopyJust a Few Vaccine Refusers Could Endanger ManyASCO Addresses Cancer Drug PricingHigh Court Rules Against Interstate Medical LiabilityFewer U.S. Dollars Spent on Cardiac Arrest Research: StudyPainkiller Prescriptions More Prone to Errors If HandwrittenFDA Panel OKs What May Soon Be First Gene Therapy Approved in U.S.Walking Rates Are Key to a Country's Obesity LevelsDocs Should Counsel Even Healthy People on Diet, Exercise, Experts SayHealth Service Use Unchanged From 1996-1997 to 2011-2012Easier Colon Exam Boosts Screening, But Insurers May Not PayMore U.S. Patients Are Recording Their Doctor VisitsMedication Mistakes Have Doubled in U.S. Since 2000: StudyMarket Competition Linked to Change in Generic Drug PricesBlood Shortage Prompts Call for DonationsBullying Takes Financial Toll on U.S. School DistrictsPoll Finds Seniors Struggling With Drug Costs Don't Seek HelpMany U.S. Teens Still Denied 'Morning After' Pill at PharmaciesOlder Americans Struggling With Drug Costs Don't Ask for HelpDoctors Urged to Take Care With Electronic CommunicationsClimate Change Likely to Widen Gap Between Rich, Poor in U.S.: StudyFDA Seeks to Increase Number of Generic Drugs on Market3 Simple Steps Might Reduce Opioid OD DeathsPhysician Attitude Important Factor in Patients Switching PCPMany Adverse Events Related to Cosmetics Go UnreportedStudy Highlights the Beauty Industry's Ugly SideMedicaid Cuts Tied to Delayed Breast Cancer DiagnosesPrimary Care Pharmacy Model Attractive to Patients1991-2014 Saw Minimal Change in Health Spending Per StateLegalized Pot May Lead to More Traffic CrashesMany Doctors Silent on Cost of Cancer CareGroup Urges Tougher Limits on Chemical in Shampoos, Cosmetics18 Percent Increase Projected in Primary Care Demand by 2023Why Patients Leave the Hospital Against Doctor's OrdersRaise the Smoking Age to 21? Most Kids Fine With ThatComprehensive Audiologic Care Feasible in Free Clinic ModelMany Tanning Salons Defy Legal Age Limits on UsersLifesaving Drugs From Pfizer in Short Supply: FDALeading U.S. Doctors' Group Takes Aim at Rising Drug PricesU.S. Hospitals Still Prescribe Too Many Antibiotics: StudyFDA Puts Brakes on Rule Requiring New 'Nutrition Facts' Label
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Some Lead Poisoning Tests May Be Faulty

HealthDay News
by -- Steven Reinberg, Robert Preidt
Updated: May 17th 2017

new article illustration

WEDNESDAY, May 17, 2017 (HealthDay News) -- Lead tests made by Magellan Diagnostics may yield inaccurate results for some children and adults, U.S. health officials warned Wednesday.

Parents of children younger than 6 years old, pregnant women and nursing mothers who have been tested for lead exposure using these tests should consult a health care provider about whether they should be retested, the officials said.

Data indicate that when all four of Magellan's lead testing systems -- LeadCare; LeadCare II; LeadCare Plus; and LeadCare Ultra -- are performed on blood drawn from a vein, they may give results that are lower than the actual level of lead in the blood.

However, lead testing using blood taken from a vein is not widespread. Most testing is done with finger pricks and heel pricks, the officials said.

"The FDA is concerned that Magellan lead tests that use blood drawn from a vein may provide results that are lower than the actual level of lead in the blood. There is little evidence that Magellan tests using blood from a finger or heel stick are affected," Dr. Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, said during a morning media briefing.

Finger pricks are used on most children. Since 2014, about 8 million tests have been performed, with the vast majority based on blood from finger or heel samples. In Flint, Mich., for example, less than 1 percent of children tested for lead had blood samples taken from a vein, the officials said.

Still, Shuren said the FDA is "deeply concerned by this situation and is warning laboratories and health care professionals that they should not use any Magellan Diagnostics' lead tests with blood drawn from a vein."

Shuren added that "the agency is aggressively investigating this complicated issue to determine the cause of the inaccurate results and working with the CDC [Centers for Disease Control and Prevention] and other public health partners to address the problem as quickly as possible."

Patrick Breysse, director of the CDC's National Center for Environmental Health, said, "We understand that parents of children and others affected by this problem will be concerned about what this means for their health.

"While most children likely received an accurate test result, it is important to identify those whose exposure was missed, or underestimated, so that they can receive proper care. For this reason, because every child's health is important, the CDC recommends that those at greatest risk be retested," Breysse said.

Lead exposure can lead to serious health problems, and is particularly dangerous to infants and young children. Recommendations for lead screening differ from state to state, but all states require children to be screened for lead exposure.

Some adults are also at risk for lead exposure, including those who work with products or materials that contain lead, the FDA said.

It's safe to use all LeadCare systems that rely on blood from a finger or heel stick, including the LeadCare II system, which is found in many doctors' offices and clinics, the officials said.

More information

The U.S. Centers for Disease Control and Prevention has more on lead.